Nutex Health, Inc. (NUTX)
USD 128.75
(12.2%)
USD 128.75
(12.2%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 66.54 Million USD | 100.02% |
| 2022 | 18.03 Million USD | 230.09% |
| 2021 | 5.46 Million USD | -95.49% |
| 2020 | 121.08 Million USD | 94.22% |
| 2019 | 62.34 Million USD | 3368.82% |
| 2018 | 1.79 Million USD | -68.39% |
| 2017 | 5.68 Million USD | 1168.76% |
| 2016 | 448.12 Thousand USD | -15.82% |
| 2015 | 532.32 Thousand USD | 0.0% |
| 2011 | 1.86 Million USD | 1.88% |
| 2010 | 1.82 Million USD | 125.98% |
| 2009 | 809.54 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 8.7 Million USD | -4.7% |
| 2024 Q2 | 10.59 Million USD | 21.63% |
| 2023 Q4 | 9.13 Million USD | 16.48% |
| 2023 Q1 | 9.07 Million USD | 43.85% |
| 2023 Q2 | 10 Million USD | 10.29% |
| 2023 Q3 | 7.84 Million USD | -21.63% |
| 2023 FY | 36.06 Million USD | 100.02% |
| 2022 Q2 | 2.48 Million USD | -86.26% |
| 2022 Q3 | 4.07 Million USD | 64.05% |
| 2022 FY | 18.03 Million USD | 230.09% |
| 2022 Q1 | 18.08 Million USD | 116.56% |
| 2022 Q4 | 6.3 Million USD | 54.74% |
| 2021 FY | 5.46 Million USD | -95.49% |
| 2021 Q2 | 1.53 Million USD | -66.5% |
| 2021 Q4 | -109.2 Million USD | -7165.29% |
| 2021 Q3 | 1.54 Million USD | 0.83% |
| 2021 Q1 | 4.57 Million USD | -89.31% |
| 2020 Q2 | 1.7 Million USD | 59.37% |
| 2020 Q4 | 42.8 Million USD | 5479.11% |
| 2020 FY | 121.08 Million USD | 94.22% |
| 2020 Q1 | 1.07 Million USD | -77.06% |
| 2020 Q3 | 767.17 Thousand USD | -55.1% |
| 2019 Q4 | 4.67 Million USD | 1193.94% |
| 2019 FY | 62.34 Million USD | 3368.82% |
| 2019 Q1 | 364.23 Thousand USD | -32.32% |
| 2019 Q3 | 361.26 Thousand USD | -3.13% |
| 2019 Q2 | 372.92 Thousand USD | 2.39% |
| 2018 Q1 | 408.23 Thousand USD | -32.71% |
| 2018 Q4 | 538.17 Thousand USD | 47.01% |
| 2018 FY | 1.79 Million USD | -68.39% |
| 2018 Q3 | 366.09 Thousand USD | -24.49% |
| 2018 Q2 | 484.84 Thousand USD | 18.77% |
| 2017 Q2 | 1.23 Million USD | 0.0% |
| 2017 Q3 | 723 Thousand USD | -41.63% |
| 2017 FY | 5.68 Million USD | 1168.76% |
| 2017 Q4 | 606.65 Thousand USD | -16.09% |
| 2016 FY | 448.12 Thousand USD | -15.82% |
| 2015 FY | 532.32 Thousand USD | 0.0% |
| 2011 Q4 | 502.09 Thousand USD | 9.49% |
| 2011 Q1 | 452.39 Thousand USD | -16.39% |
| 2011 Q2 | 450.66 Thousand USD | -0.38% |
| 2011 Q3 | 458.57 Thousand USD | 1.76% |
| 2011 FY | 1.86 Million USD | 1.88% |
| 2010 FY | 1.82 Million USD | 125.98% |
| 2010 Q4 | 541.09 Thousand USD | 25.96% |
| 2010 Q3 | 429.56 Thousand USD | 0.09% |
| 2010 Q1 | 429.56 Thousand USD | 0.0% |
| 2010 Q2 | 429.17 Thousand USD | -0.09% |
| 2009 FY | 809.54 Thousand USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Ontrak, Inc. | 29.47 Million USD | -125.778% |
| iCoreConnect Inc. | 15.12 Million USD | -340.013% |
| Augmedix, Inc. | 40.3 Million USD | -65.111% |
| BrightSpring Health Services, Inc. Common Stock | 1.28 Billion USD | 94.828% |
| CareCloud, Inc. | 93.35 Million USD | 28.717% |
| CareCloud, Inc. | 93.35 Million USD | 28.717% |
| HealthEquity, Inc. | 401.74 Million USD | 83.435% |
| Inovalon Holdings, Inc. | 427.99 Million USD | 84.451% |
| OneMedNet Corporation | 8.24 Million USD | -706.998% |
| Progyny, Inc. | 176.61 Million USD | 62.32% |
| Omnicell, Inc. | 534.79 Million USD | 87.556% |
| Renalytix Plc | 29.04 Million USD | -129.152% |
| Schrödinger, Inc. | 318.14 Million USD | 79.082% |
| Simulations Plus, Inc. | 37.02 Million USD | -79.762% |
| SOPHiA GENETICS SA | 117.73 Million USD | 43.478% |
| Streamline Health Solutions, Inc. | 31.19 Million USD | -113.363% |
| Minerva Surgical, Inc. | 58.14 Million USD | -14.46% |
| GE HealthCare Technologies Inc. | 5.48 Billion USD | 98.787% |
| Sharecare, Inc. | 225.97 Million USD | 70.551% |
| Aclarion, Inc. | 4.87 Million USD | -1264.902% |
| CareMax, Inc. | 670.05 Million USD | 90.068% |
| Bullfrog AI Holdings, Inc. Common Stock | 5.42 Million USD | -1126.164% |
| Forian Inc. | 20.59 Million USD | -223.059% |
| Bullfrog AI Holdings, Inc. Warrants | 5.42 Million USD | -1126.164% |
| HeartBeam, Inc. | 15.31 Million USD | -334.556% |
| GeneDx Holdings Corp. | 224.28 Million USD | 70.329% |
| SCWorx Corp. | 2.71 Million USD | -2346.849% |
| Definitive Healthcare Corp. | 546.47 Million USD | 87.822% |
| 10x Genomics, Inc. | 674.94 Million USD | 90.14% |
| Zhongchao Inc. | 13.92 Million USD | -377.989% |
| Accolade, Inc. | 306.51 Million USD | 78.289% |
| MSP Recovery, Inc. | 565.43 Million USD | 88.231% |
| R1 RCM Inc. | 336.6 Million USD | 80.229% |
| Spok Holdings, Inc. | 90.97 Million USD | 26.854% |
| Privia Health Group, Inc. | 134.31 Million USD | 50.455% |
| EUDA Health Holdings Limited | 4.8 Million USD | -1285.512% |
| TruBridge, Inc. | 206.17 Million USD | 67.722% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 1.28 Billion USD | 94.828% |
| Sharecare, Inc. | 225.97 Million USD | 70.551% |
| Health Catalyst, Inc. | 258.73 Million USD | 74.279% |
| GoodRx Holdings, Inc. | 710.34 Million USD | 90.632% |
| Premier, Inc. | 683.65 Million USD | 90.266% |
| HealthStream, Inc. | 168.02 Million USD | 60.394% |
| Certara, Inc. | 254.08 Million USD | 73.809% |
| GeneDx Holdings Corp. | 224.28 Million USD | 70.329% |
| Ontrak, Inc. | 29.47 Million USD | -125.778% |
| SHL Telemedicine Ltd. | 34.26 Million USD | -94.204% |
| CareCloud, Inc. | 93.35 Million USD | 28.717% |
| EUDA Health Holdings Limited | 4.8 Million USD | -1285.512% |
| HeartBeam, Inc. | 15.31 Million USD | -334.556% |
| Mangoceuticals, Inc. | 9.65 Million USD | -589.588% |
| CareMax, Inc. | 670.05 Million USD | 90.068% |
| Healthcare Triangle, Inc. | 18.12 Million USD | -267.161% |
| National Research Corporation | 52.52 Million USD | -26.71% |
| Aclarion, Inc. | 4.87 Million USD | -1264.902% |
| OptimizeRx Corporation | 69.3 Million USD | 3.974% |